Skip to main content
Commentaries
About Us
Contact Us
Media Appearances
Follow Us
An F.D.A. panel recommended against approving a Pfizer-BioNTech booster for people 16 and older.
https://www.nytimes.com/live/2021/09/17/world/covid-delta-variant-vaccine#fda-booster-shots-meeting-covid
Noah Weiland and Sharon LaFraniere
New York Times
September 17, 2021
